Albany Molecular Research Inc. (AMRI) and BioPontis Alliance LLC Enter Preferred Provider Agreement to Identify New Drug Opportunities
Albany Molecular Research Inc., an Albany based global contract services and manufacturing organization, announced today that it will work with BioPontis Alliance, LLC in a preferred provider agreement to support BioPontis’ mission to bridge the gap between early stage research and technologies that come out of academia and other research outlets. AMRI will provide its expertise in small molecule discovery, development, and manufacturing. The partnership is expected to help find promising early stage product opportunities and create a preferred network of leading research companies to help develop new drugs to attract pharmaceutical company licensing partners. BioPontis has formed research alliances…